MSFT: Inflection Point Narrative vs. WAIT Rating – No Thesis Shift

What happened

Microsoft shares are down ~30% from highs despite ~17% EPS growth, with a Seeking Alpha article arguing the market misprices AI integration and that Azure's 40% growth will accelerate as capacity constraints resolve by end-FY26. However, the DeepValue master report maintains a WAIT rating, citing that Azure's capacity limits may persist, cloud gross margin is stepping down from 66% to ~64%, and calendar 2026 capex of ~$190B keeps return-on-capital unproven. The article's inflection point thesis is plausible but hinges on execution—Azure must show the promised modest acceleration and margins must stabilize. The DeepValue report already incorporates the bull case (Azure >40%, margins >64%) as a 25% probability scenario. Thus, the narrative does not alter the core thesis: wait for Q4 FY26 and early FY27 evidence.

Implication

If capacity unlocks as management guides, Azure growth re-accelerates, and cloud gross margin stabilizes, the stock offers significant upside from current ~23x P/E. However, evidence from Q4 FY26 and early FY27 is required before conviction can increase.

Thesis delta

No material shift. The article reinforces the bull scenario already captured in DeepValue's 25% probability Bull case (Azure 43-45%, margins ~66%). The WAIT rating remains appropriate until capacity conversion and margin trajectory are confirmed. The thesis continues to hinge on Azure growth acceleration and cloud margin stabilization in the next 6-9 months.